| RS2107670401 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107670410 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107670416 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107670420 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2107670425 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107670463 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107670467 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107670484 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107670492 |
GATA2
|
Health Risk |
Pathogenic |
— |
| RS2107670544 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107671906 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2107671923 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107671950 |
COL7A1
|
Health Risk |
Likely pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107671960 |
COL7A1
|
Health Risk |
Pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, COL7A1-related disorder |
| RS2107671965 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672019 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2107672055 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672102 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672112 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107672153 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672186 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672252 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672306 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672309 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672336 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672419 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672568 |
GATA2
|
Health Risk |
Pathogenic |
Monocytopenia with susceptibility to infections, Deafness-lymphedema-leukemia syndrome |
| RS2107672654 |
GATA2
|
Health Risk |
Pathogenic |
Monocytopenia with susceptibility to infections, Deafness-lymphedema-leukemia syndrome |
| RS2107672698 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Transient bullous dermolysis of the newborn, Transient bullous dermolysis of the newborn |
| RS2107672703 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672708 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672730 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672732 |
COL7A1
|
Health Risk |
Likely pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107672756 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107672777 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107672783 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672788 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672816 |
COL7A1
|
Health Risk |
Pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107672844 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672847 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672869 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672881 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672888 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672963 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107672967 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107673392 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107673397 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107673501 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107673544 |
GATA2
|
Health Risk |
Pathogenic |
GATA2 deficiency with susceptibility to MDS/AML, Deafness-lymphedema-leukemia syndrome |
| RS2107673633 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107673689 |
GATA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107673777 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107673815 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107674135 |
COL7A1
|
Health Risk |
Pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107674146 |
SETD2
|
Health Risk |
Likely pathogenic |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS2107674192 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107674323 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107674627 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107674698 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107674937 |
COL7A1
|
Health Risk |
Likely pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Transient bullous dermolysis of the newborn |
| RS2107675021 |
COL7A1
|
Health Risk |
Pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107675136 |
COL7A1
|
Health Risk |
Pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107675162 |
COL7A1
|
Health Risk |
Pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107679315 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107680218 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107680342 |
COL7A1
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa pruriginosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107680443 |
COL7A1
|
Health Risk |
Likely pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107682223 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107682264 |
COL7A1
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa pruriginosa, Recessive dystrophic epidermolysis bullosa |
| RS2107683470 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107690909 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107691045 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107692123 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107694864 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107696360 |
SETD2
|
Health Risk |
Pathogenic |
Luscan-Lumish syndrome, Neoplasm |
| RS2107697174 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, COL7A1-related disorder |
| RS2107697936 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107698224 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107698800 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107698884 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107699672 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107702819 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107703081 |
COL7A1
|
Health Risk |
Likely pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107706848 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107706875 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107710536 |
COL7A1
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS2107711734 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107712587 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107713521 |
PTPN23
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity, Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity |
| RS2107714011 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107714139 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107715075 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2107717354 |
PTPN23
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2107717630 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107717803 |
COL7A1
|
Health Risk |
Likely pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107717836 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107718927 |
COL7A1
|
Health Risk |
Pathogenic |
COL7A1-related disorder, COL7A1-related disorder |
| RS2107720258 |
PTPN23
|
Health Risk |
Likely pathogenic |
— |
| RS2107722847 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107725917 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |